Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Smith & Nephew
SNN
$13.7B
| $273K | ﹤0.01% |
+10,117
| New | +$254K |
|
3552
Invesco California Value Municipal Income Trust
VCV
$517M
| $273K | ﹤0.01% |
28,776
+9,857
| +52% | +$91.4K |
|
3553
John Hancock Multifactor Emerging Markets ETF
JHEM
$949M
| $271K | ﹤0.01% |
11,744
-4,718
| -29% | -$108K |
|
3554
Qfin Holdings
QFIN
$1.68B
| $271K | ﹤0.01% |
13,251
-2,381
| -15% | -$35.4K |
|
3555
Dyne Therapeutics
DYN
$4.68B
| $269K | ﹤0.01% |
23,220
| – | – |
|
3556
Omeros
OMER
$845M
| $269K | ﹤0.01% |
118,966
-1,200
| -1% | -$3.31K |
|
3557
Lazard
LAZ
$3.96B
| $268K | ﹤0.01% |
7,754
-17
| -0.2% | -$604 |
|
|
ESPR
3558
DELISTED
Esperion Therapeutics
ESPR
| $267K | ﹤0.01% |
42,951
+12
| +0% | +$86 |
|
3559
Sabesp
SBS
$18.4B
| $267K | ﹤0.01% |
129,511
-2,393
| -2% | -$5.05K |
|
3560
SelectQuote
SLQT
$122M
| $267K | ﹤0.01% |
398,084
-475,126
| -54% | -$311K |
|
3561
AngloGold Ashanti
AU
$39.4B
| $266K | ﹤0.01% |
13,734
+3,713
| +37% | +$60.9K |
|
3562
iShares MSCI Switzerland ETF
EWL
$2.17B
| $266K | ﹤0.01% |
6,345
-22,872
| -78% | -$930K |
|
3563
Peloton Interactive
PTON
$2.85B
| $266K | ﹤0.01% |
33,496
+3,353
| +11% | +$32.2K |
|
3564
HUTCHMED
HCM
$1.96B
| $264K | ﹤0.01% |
+17,860
| New | +$195K |
|
|
QIWI
3565
DELISTED
QIWI PLC
QIWI
| $264K | ﹤0.01% |
65,035
-2,042
| -3% | -$8.29K |
|
3566
ACNB Corp
ACNB
$646M
| $263K | ﹤0.01% |
+6,610
| New | +$241K |
|
3567
Arcturus Therapeutics
ARCT
$165M
| $263K | ﹤0.01% |
15,530
+1,510
| +11% | +$26.3K |
|
|
AXIA
3568
AXIA Energia
AXIA
$22.9B
| $263K | ﹤0.01% |
41,834
+575
| +1% | +$3.91K |
|
3569
BGSF Inc
BGSF
$57.4M
| $262K | ﹤0.01% |
17,115
| – | – |
|
|
NXC
3570
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
| $262K | ﹤0.01% |
+18,225
| New | +$242K |
|
3571
AquaBounty Technologies
AQB
$4.73M
| $261K | ﹤0.01% |
17,156
-205
| -1% | -$2.79K |
|
|
LBC
3572
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $260K | ﹤0.01% |
23,383
-5,043
| -18% | -$59.2K |
|
3573
WisdomTree Europe SmallCap Dividend Fund
DFE
$164M
| $258K | ﹤0.01% |
4,722
+18
| +0.4% | +$930 |
|
|
MOMO
3574
Hello Group
MOMO
$867M
| $257K | ﹤0.01% |
28,547
+10,539
| +59% | +$62.5K |
|
3575
Surgery Partners
SGRY
$2.15B
| $257K | ﹤0.01% |
+9,237
| New | +$245K |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.